Neuronetics (STIM) Net Cash Flow Growth (1y) (2018 - 2026)
Neuronetics (STIM) Net Cash Flow Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.95 Bn | 176.66 Bn | 6.27 Bn | -53.07% |
| 2 | Stryker | 128.80 Bn | 125.92 Bn | 3.81 Bn | 17.60% |
| 3 | Medtronic | 108.82 Bn | 99.60 Bn | 6.41 Bn | 10.50% |
| 4 | Boston Scientific | 68.54 Bn | 67.08 Bn | 3.61 Bn | -283.58% |
| 5 | Edwards Lifesciences | 48.37 Bn | 44.70 Bn | 1.29 Bn | -564.44% |
| 6 | Dexcom | 28.41 Bn | 27.30 Bn | 750.30 Mn | -31.84% |
| 7 | GE HealthCare Technologies | 28.33 Bn | 26.04 Bn | 1.98 Bn | -394.13% |
| 8 | Smith & Nephew | 26.96 Bn | 26.38 Bn | - | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.31 Bn | 2.07 Bn | 76.43% |
| 10 | Neuronetics | 120.39 Mn | 114.38 Mn | 16.15 Mn | -959.49% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -959.49% |
| Dec 31, 2025 | 75.50% |
| Sep 30, 2025 | 414.40% |
| Jun 30, 2025 | 26.14% |
| Mar 31, 2025 | 114.77% |
| Dec 31, 2024 | -105.91% |
| Sep 30, 2024 | 46.28% |
| Jun 30, 2024 | 46.66% |
| Mar 31, 2024 | 19.80% |
| Dec 31, 2023 | 809.65% |
| Sep 30, 2023 | -463.50% |
| Jun 30, 2023 | 3.71% |
| Mar 31, 2023 | -11.97% |
| Dec 31, 2022 | 36.76% |
| Sep 30, 2022 | 116.92% |
| Jun 30, 2022 | -80.31% |
| Mar 31, 2022 | -118.40% |
| Dec 31, 2021 | -201.36% |
| Sep 30, 2021 | -398.90% |
| Jun 30, 2021 | 43.07% |